174 related articles for article (PubMed ID: 34687971)
1. Metabolic Syndrome and Risk of Gastrointestinal Cancers: An Investigation Using Large-scale Molecular Data.
Rothwell JA; Jenab M; Karimi M; Truong T; Mahamat-Saleh Y; Ferrari P; Dashti SG; Kühn T; Cross AJ; Severi G; Gunter MJ; Murphy N
Clin Gastroenterol Hepatol; 2022 Jun; 20(6):e1338-e1352. PubMed ID: 34687971
[TBL] [Abstract][Full Text] [Related]
2. Genetic risk, metabolic syndrome, and gastrointestinal cancer risk: A prospective cohort study.
Liu Y; Yan C; Yin S; Wang T; Zhu M; Liu L; Jin G
Cancer Med; 2023 Jan; 12(1):597-605. PubMed ID: 35730595
[TBL] [Abstract][Full Text] [Related]
3. Circulating Sex Hormones Are Associated With Gastric and Colorectal Cancers but Not Esophageal Adenocarcinoma in the UK Biobank.
McMenamin ÚC; Liu P; Kunzmann AT; Cook MB; Coleman HG; Johnston BT; Cantwell MM; Cardwell CR
Am J Gastroenterol; 2021 Mar; 116(3):522-529. PubMed ID: 33156012
[TBL] [Abstract][Full Text] [Related]
4. Metabolic syndrome and esophageal and gastric cancer.
Lin Y; Ness-Jensen E; Hveem K; Lagergren J; Lu Y
Cancer Causes Control; 2015 Dec; 26(12):1825-34. PubMed ID: 26450604
[TBL] [Abstract][Full Text] [Related]
5. Metabolic syndrome, its components, and gastrointestinal cancer risk: a meta-analysis of 31 prospective cohorts and Mendelian randomization study.
Zhan ZQ; Chen YZ; Huang ZM; Luo YH; Zeng JJ; Wang Y; Tan J; Chen YX; Fang JY
J Gastroenterol Hepatol; 2024 Apr; 39(4):630-641. PubMed ID: 38230882
[TBL] [Abstract][Full Text] [Related]
6. Metabolic syndrome and risks of colon and rectal cancer: the European prospective investigation into cancer and nutrition study.
Aleksandrova K; Boeing H; Jenab M; Bas Bueno-de-Mesquita H; Jansen E; van Duijnhoven FJ; Fedirko V; Rinaldi S; Romieu I; Riboli E; Romaguera D; Overvad K; Østergaard JN; Olsen A; Tjønneland A; Boutron-Ruault MC; Clavel-Chapelon F; Morois S; Masala G; Agnoli C; Panico S; Tumino R; Vineis P; Kaaks R; Lukanova A; Trichopoulou A; Naska A; Bamia C; Peeters PH; Rodríguez L; Buckland G; Sánchez MJ; Dorronsoro M; Huerta JM; Barricarte A; Hallmans G; Palmqvist R; Khaw KT; Wareham N; Allen NE; Tsilidis KK; Pischon T
Cancer Prev Res (Phila); 2011 Nov; 4(11):1873-83. PubMed ID: 21697276
[TBL] [Abstract][Full Text] [Related]
7. Metabolic syndrome and risk of pancreatic cancer: A population-based prospective cohort study.
Xia B; He Q; Pan Y; Gao F; Liu A; Tang Y; Chong C; Teoh AYB; Li F; He Y; Zhang C; Yuan J
Int J Cancer; 2020 Dec; 147(12):3384-3393. PubMed ID: 32580250
[TBL] [Abstract][Full Text] [Related]
8. Association Between Metabolic Syndrome and Risk of Esophageal Cancer: a Nationwide Population-Based Study.
Lee JE; Han K; Yoo J; Yeo Y; Cho IY; Cho B; Park JH; Shin DW; Cho JH; Park YM
Cancer Epidemiol Biomarkers Prev; 2022 Dec; 31(12):2228-2236. PubMed ID: 36166509
[TBL] [Abstract][Full Text] [Related]
9. Metabolic risk factors for esophageal squamous cell carcinoma and adenocarcinoma: a prospective study of 580,000 subjects within the Me-Can project.
Lindkvist B; Johansen D; Stocks T; Concin H; Bjørge T; Almquist M; Häggström C; Engeland A; Hallmans G; Nagel G; Jonsson H; Selmer R; Ulmer H; Tretli S; Stattin P; Manjer J
BMC Cancer; 2014 Feb; 14():103. PubMed ID: 24548688
[TBL] [Abstract][Full Text] [Related]
10. Association between metabolic syndrome and kidney cancer risk: a prospective cohort study.
Wang L; Du H; Sheng C; Dai H; Chen K
Lipids Health Dis; 2024 May; 23(1):142. PubMed ID: 38760801
[TBL] [Abstract][Full Text] [Related]
11. The association of metabolic syndrome score trajectory patterns with risk of all cancer types.
Deng L; Liu T; Liu CA; Zhang Q; Song MM; Lin SQ; Wang YM; Zhang QS; Shi HP
Cancer; 2024 Jun; 130(12):2150-2159. PubMed ID: 38462898
[TBL] [Abstract][Full Text] [Related]
12. Metabolic syndrome and risk of esophageal adenocarcinoma in elderly patients in the United States: An analysis of SEER-Medicare data.
Drahos J; Ricker W; Pfeiffer RM; Cook MB
Cancer; 2017 Feb; 123(4):657-665. PubMed ID: 27861759
[TBL] [Abstract][Full Text] [Related]
13. Changes in Metabolic Syndrome Status are Associated With Altered Risk of Pancreatic Cancer: A Nationwide Cohort Study.
Park JH; Han K; Hong JY; Park YS; Hur KY; Kang G; Park JO
Gastroenterology; 2022 Feb; 162(2):509-520.e7. PubMed ID: 34653420
[TBL] [Abstract][Full Text] [Related]
14. Risk and Predictors of Esophageal and Stomach Cancers in HIV-Infected Veterans: A Matched Cohort Study.
Thrift AP; Kramer JR; Hartman CM; Royse K; Richardson P; Dong Y; Raychaudhury S; Desiderio R; Sanchez D; Anandasabapathy S; White DL; Chiao EY
J Acquir Immune Defic Syndr; 2019 Jul; 81(3):e65-e72. PubMed ID: 30939533
[TBL] [Abstract][Full Text] [Related]
15. Metabolic syndrome and its component traits present gender-specific association with liver cancer risk: a prospective cohort study.
Xia B; Peng J; Enrico T; Lu K; Cheung EC; Kuo Z; He Q; Tang Y; Liu A; Fan D; Zhang C; He Y; Pan Y; Yuan J
BMC Cancer; 2021 Oct; 21(1):1084. PubMed ID: 34620113
[TBL] [Abstract][Full Text] [Related]
16. Nut and peanut butter consumption and the risk of esophageal and gastric cancer subtypes.
Hashemian M; Murphy G; Etemadi A; Dawsey SM; Liao LM; Abnet CC
Am J Clin Nutr; 2017 Sep; 106(3):858-864. PubMed ID: 28768652
[No Abstract] [Full Text] [Related]
17. Association of Metabolic Syndrome With Risk of Lung Cancer: A Population-Based Prospective Cohort Study.
Li M; Cao SM; Dimou N; Wu L; Li JB; Yang J
Chest; 2024 Jan; 165(1):213-223. PubMed ID: 37572975
[TBL] [Abstract][Full Text] [Related]
18. Association between metabolic syndrome and its components and incident colorectal cancer in a prospective cohort study.
Tran TT; Gunathilake M; Lee J; Kim J
Cancer; 2022 Mar; 128(6):1230-1241. PubMed ID: 34762301
[TBL] [Abstract][Full Text] [Related]
19. Visceral obesity with and without metabolic syndrome: incidence and clinical impact in esophageal adenocarcinoma treated with curative intent.
Elliott JA; Donlon NE; Beddy P; Donohoe CL; Doyle SL; King S; Ravi N; Reynolds JV
Dis Esophagus; 2022 Sep; 35(9):. PubMed ID: 35039840
[TBL] [Abstract][Full Text] [Related]
20. Impact of metabolic syndrome on the survival of Chinese patients with resectable esophageal squamous cell carcinoma.
Wen YS; Huang C; Zhang X; Qin R; Lin P; Rong T; Zhang LJ
Dis Esophagus; 2016 Aug; 29(6):607-13. PubMed ID: 26123618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
